Investing.com -- ParaZero Technologies Ltd (NASDAQ: PRZO) stock surged 7% following a successful live demonstration of its DefendAir Personal Net Gun System for Israeli defense officials, which ...

Investing.com -- JPMorgan analysts say the passage of the “One Big Beautiful Bill" Act on July 4 has brought long-awaited clarity to U.S. clean energy policy, which could pave the way for renewed ...

UBS assumed coverage on several U.S. airline stocks with a cautious tone, initiating JetBlue Airways (NASDAQ: JBLU) with a ...

Investing.com - Changes to bonus depreciation for business equipment purchases and tax breaks for interest expenses should ...

Jasper Therapeutics (NASDAQ: JSPR) shares fell 43.7% in premarket trading after the company reported problems with one of its drug product lots. The company discl ...

Goldman Sachs strategist Christian Mueller-Glissmann warned that markets may be too relaxed about tariffs as investors continue to bet on a favorable economic environment. "If uncertainty picks up on ...

Yardeni Research has raised concerns over President Donald Trump’s efforts to lower government borrowing costs, warning that ...

Investing.com -- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) stock surged 19% after the company announced FDA approval of EKTERLY (sebetralstat), the first and only oral on-demand treatment for ...

Rocket Lab USA (NASDAQ: RKLB) stock rose 3% in pre-market trading on Monday as investors shifted attention to SpaceX competitors amid Elon Musk’s escalating pol ...

Sandstorm Gold (NYSE: SAND) stock rose 7% after Royal Gold (NASDAQ: RGLD) announced plans to acquire both Sandstorm and Horizon Copper in a move to strengthen its ...

Investing.com -- Cogent Biosciences, Inc. (NASDAQ: COGT) stock surged 10% after announcing positive top-line results from its SUMMIT trial of bezuclastinib in patients with non-advanced systemic ...

Therapeutics, Inc. (NASDAQ:APGE) stock surged 24% on Monday after the clinical-stage biotechnology company announced positive 16-week data from its Phase 2 APEX clinical trial of APG777 in moderate-to ...